LAVA Therapeutics (LVTX) SEC Filings & 10K Form $0.94 +0.00 (+0.06%) As of 01/17/2025 04:00 PM Eastern Add Compare Share Share SEC Filings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrends Recent LAVA Therapeutics SEC Filings All Filing Types 1 10 10-D 10-K 10-M 10-Q 11-K 12b-25 13F 13H 144 15 15F 17-H 18 18-K 19b-4(e) 19b-4 19b-7 1-A 1-E 1-K 1-N 1-SA 1-U 1-Z 20-F 24F-2 25 2-E 3 4 40-F 5 6-K 7-M 8-A 8-K 8-M 9-M ABS DD-15E ABS-15G ABS-EE ADV ADV-E ADV-H ADV-NR ADV-W ATS ATS-R BD BD-N BDW C CA-1 CB CFPORTAL D F-1 F-10 F-3 F-4 F-6 F-7 F-8 F-80 F-N F-X ID MA MA-I MA-NR MA-W MSD MSDW n/a N-14 N-17D-1 N-17f-1 N-17f-2 N-18f-1 N-1A N-2 N-23c-3 N-27D-1 N-3 N-4 N-5 N-54A N-54C N-6 N-6EI-1 N-6F N-8A N-8B-2 N-8B-4 N-8F N-CR N-CSR N-MFP N-PX N-Q NRSRO N-SAR PF PILOT R31 S-1 S-11 S-20 S-3 S-4 S-6 S-8 SBSE SBSE-A SBSE-BD SBSE-C SBSE-W SCI SD SDR SE SF-1 SF-3 SIP T-1 T-2 T-3 T-4 T-6 TA-1 TA-2 TA-W TCR TH WB-APP X-17A-19 X-17A-5 Part I X-17A-5 Part II X-17A-5 Part IIA X-17A-5 Part IIB X-17A-5 Part III X-17A-5 Schedule I X-17F-1A Filing Types Include Ownership Filings Exclude Ownership Filings Only Show Ownership FIlings Ownership Filings Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel DateFilerForm TypeView01/02/20258:26 AMDhingra Kapil (Reporting)LAVA Therapeutics (Issuer)Form 3Initial statement of beneficial ownership of securities 01/02/20258:28 AMBackstrom Jay T. (Reporting)LAVA Therapeutics (Issuer)Form 3Initial statement of beneficial ownership of securities 01/02/20258:29 AMKiener Peter A (Reporting)LAVA Therapeutics (Issuer)Form 3Initial statement of beneficial ownership of securities 01/02/20258:31 AMLAVA Therapeutics (Issuer)Noble James (Reporting)Form 3Initial statement of beneficial ownership of securities 01/02/20258:32 AMLAVA Therapeutics (Issuer)Oliger Christy J. (Reporting)Form 3Initial statement of beneficial ownership of securities 01/02/20258:34 AMLAVA Therapeutics (Issuer)Wadlinger Mary E. (Reporting)Form 3Initial statement of beneficial ownership of securities 01/02/20258:35 AMLAVA Therapeutics (Issuer)WILSON KAREN J (Reporting)Form 3Initial statement of beneficial ownership of securities 01/02/20258:19 AMHURLY STEPHEN A (Reporting)LAVA Therapeutics (Issuer)Form 3Initial statement of beneficial ownership of securities 01/02/20258:20 AMLAVA Therapeutics (Issuer)Powell Fred M (Reporting)Form 3Initial statement of beneficial ownership of securities 01/02/20258:21 AMLAVA Therapeutics (Issuer)Morris Charles Q (Reporting)Form 3Initial statement of beneficial ownership of securities 01/02/20257:45 AMLAVA Therapeutics (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 03/21/20246:05 AMLAVA Therapeutics (Filer)Form 6-KReport of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 03/07/20246:09 PMLAVA Therapeutics (Subject)Novo Holdings A/S (Filed by)Form SC 13D/A(Data available from 1/1/2016 forward) Related Companies and Tools Related Companies 180 Life Sciences 10Q Form 4D pharma 10Q Form Aesther Healthcare Acquisition 10Q Form Ainos 10Q Form Alvotech 10Q Form Atlantic Coastal Acquisition Corp. II 10Q Form Biofrontera 10Q Form biote 10Q Form BriaCell Therapeutics 10Q Form Celularity 10Q Form SEC Filings Tools Latest SEC FilingsInsider Trading Activity This page (NASDAQ:LVTX) was last updated on 1/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredStunning Trump Exec Order LeakedThis secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode in 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe crypto bull market is here, and the stakes couldn’t be higher. The next 3-6 months? They’re the most ex...Crypto Swap Profits | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredElon’s New AI Firm REVEALEDNvidia’s AI chip … the H100 … has been the holy grail of artificial intelligence… Until now. Because Elo...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding LAVA Therapeutics Please log in to your account or sign up in order to add this asset to your watchlist. Share LAVA Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free LVTX Stock Alerts